Hormone-sensitive cancers, particularly hormone receptor–positive breast cancer, rely on estrogen to grow and spread. In postmenopausal women, reducing estrogen levels is a key therapeutic strategy to slow disease progression and improve long-term outcomes. Anastrozole 1 mg has emerged as one of the most effective and widely prescribed treatments in this category. By directly targeting estrogen […]